维普期刊资源整合服务平台（V6.5）

64篇 您的检索式：作者名="Morandi N"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	The ptoteasome in- hibitor bortezomib affects osteoblast differentiation in vitro and vivo in multiple myeloma patients显示文摘	Giuliani N Morandi F Tagliaferri S	2007	Blood2007，110，：	1
2	The proteasome inhibitor bortezomib affects osteoblast differentiation in vitro and in vivo in multiple myeloma patients显示文摘	Giuliani N Morandi F Tagliaferri S	2007	Blood2007，110，1：	1
3	Myeloma cells block RUNX2/CB- FA1 activity in humanbone marrow osteoblast progenitors and inhibit oste- oblast formation and differentiation 显示文摘	Giuliani N Colla S Morandi F	2005	Blood2005，106，7：	1
4	Chemokine receptors in advanced breast cancer: differential expression in metastatic disease sites with diagnostic and therapeutic implications显示文摘	Cabioglu N Sahin AA Morandi P	2009	Ann Oncol2009，20，6：	1
5	The emerging role of soluble HLA-G in the control of chemotaxis显示文摘	Morandi F Rouas-Freiss N Pistoia V	2014	Cytokine Growth Factor Rev2014，25，3：	1
6	Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma -induced angiogenesis显示文摘	Giuliani N Lunghi P Morandi F	2004	Leukemia2004，18，3：	1
7	Manipulating the ehemokine-ehemokine receptor network to treat eancer显示文摘	Ruffini P A Morandi P Cabioglu N	2007	Cancer2007，109，12：	1
8	Chemokine receptors in advanced breast cancer: differential expression in metastatic dis- ease sites with diagnostic and therapeutic implications显示文摘	Cabioglu N Sahin AA Morandi P	2009	Ann On- col2009，20，6：	1
9	Morphologic, molecular, and pathogenic characterization of Diaporthe phaseolorum variability in the core soybean-producing area of Argentina 显示文摘	Poili R N Morandi E N Martinez M C	2003	Phytopathology2003，93，：	1
10	Myeloma cells block RUNX2/CBFAL 1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast for mation and differentiation显示文摘	Giuliani N Colla S Morandi F	2005	Blood2005，106，5：	1
11	Chemokine receptors in advanced breast cancer:differential expression in metastatic disease sites with diagnostic and therapeutic implications显示文摘	Cabioglu N Sahin AA Morandi P	2009	Ann Oncol2009，20，6：	1
12	Morphologic, molecular, and pathogenic characterization of Diaporthe phaseolorum variability in the core soybean-producing area of Argentina 显示文摘	Pioli R N Morandi E N Martinez M C	2003	Phytopathology2003，93，2：	1
13	Intedeukin-3 (IL-3) is Overexpressed by T Lymphocytes in Multiple Myeloma Patients 显示文摘	Giuliani N Morandi F Tagliaferri S	2006	Blood2006，107，：	1
14	The proteasome inhibitor bortezomib affects osteoblast differentiation in vitro and in vivo in multiple myeloma patients显示文摘	Gittliani N Morandi F Tagliaferri S	2007	Blood2007，110，1：	1
15	The proteasome inhibitor bortezomib affects osteoblast differentiation in vitro and in vitro in multiple myeloma patients显示文摘	Giuliani N Morandi F Tagliaferri S	2007	Blood2007，110，1：	1
16	Myelomacells block RUNX2/CBFA1 activity in human bonemarrow osteoblastprogenitors and inhibit osteoblastformation and differentiation 显示文摘	Giuliani N Colla S Morandi F	2005	Blood2005，106，7：	1
17	Angiopoietin-1 and myeloma-induced angiogenesis显示文摘	Giuliani N Colla S Morandi F	2005	Leuk Lymphoma2005，46，1：	1
18	The Proteasome Inhibitor Bortezomib Affects Osteoblast Differentiation in Vitro and in Vivo in Multiple Myeloma Patients 显示文摘	Giuliani N Morandi F Tagliaferri S	2007	Blood2007，110，：	1
19	Chemokine receptors in advanced breast cancer:differential expression in metastatic disease sites with diagnostic and therapeutic implications显示文摘	Cabioglu N Sahin AA Morandi P	2009	Ann Oncol2009，20，6：	1
20	The proteasome inhibitor bortezomib affects osteo- blast differentiation in vitro and in vivo in multiple myelo- ma patients显示文摘	GIULIANI N MORANDI F TAGLIAFERRI S	2007	Blood2007，110，：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示